Cancer Chemotherapy Market (By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Leukemia, Ovarian Cancer, Others; By Drug Class: Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, Antitumor Antibiotic, Others; By Route Of Administration: Intravenous, Oral, Subcutaneous, Intra-Muscular, Intravesicular, Topical, Intraperitoneal, Intraventricular/Intrathecal, Others; By End User: Specialty Centers, Hospitals & Clinics, Others) - Global Industry Analysis, Market Size, Opportunities And Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Cancer Chemotherapy
1.1. Definition and Scope
1.1.1. Definition of Cancer Chemotherapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cancer Chemotherapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cancer Chemotherapy Market By Indication
1.2.3. Cancer Chemotherapy Market By Drug Class
1.2.4. Cancer Chemotherapy Market By Route of Administration
1.2.5. Cancer Chemotherapy Market By End User
1.2.6. Cancer Chemotherapy Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Chemotherapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cancer Chemotherapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Cancer Chemotherapy Market By Indication
4.1. Introduction
4.2. Cancer Chemotherapy Revenue By Indication
4.2.1. Cancer Chemotherapy Revenue (US$ Mn) and Forecast, By Indication, 2016-2027
4.2.2. Lung Cancer
4.2.2.1. Lung Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Breast Cancer
4.2.3.1. Breast Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Colorectal Cancer
4.2.4.1. Colorectal Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Prostate Cancer
4.2.5.1. Prostate Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Stomach Cancer
4.2.6.1. Stomach Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Lymphoma
4.2.7.1. Lymphoma Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.8. Leukemia
4.2.8.1. Leukemia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.9. Ovarian Cancer
4.2.9.1. Ovarian Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.10. Others
4.2.10.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 5. Cancer Chemotherapy Market By Drug Class
5.1. Introduction
5.2. Cancer Chemotherapy Revenue By Drug Class
5.2.1. Cancer Chemotherapy Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
5.2.2. Alkylating agents
5.2.2.1. Alkylating agents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Mitotic inhibitors
5.2.3.1. Mitotic inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Antimetabolites
5.2.4.1. Antimetabolites Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Topoisomerase Inhibitors
5.2.5.1. Topoisomerase Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Antitumor antibiotic
5.2.6.1. Antitumor antibiotic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Others
5.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Cancer Chemotherapy Market Revenue By Route of Administration
6.1. Introduction
6.2. Cancer Chemotherapy Revenue (US$ Mn) By Route of Administration
6.2.1. Cancer Chemotherapy Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
6.2.2. Intravenous
6.2.2.1. Intravenous Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Oral
6.2.3.1. Oral Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Subcutaneous
6.2.4.1. Subcutaneous Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Intra-Muscular
6.2.5.1. Intra-Muscular Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Intravesicular
6.2.6.1. Intravesicular Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Topical
6.2.7.1. Topical Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.8. Intraperitoneal
6.2.8.1. Intraperitoneal Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.9. Intraventricular/Intrathecal
6.2.9.1. Intraventricular/Intrathecal Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.10. Others
6.2.10.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Cancer Chemotherapy Market By End User
7.1. Introduction
7.2. Cancer Chemotherapy Revenue (US$ Mn) By End User
7.2.1. Cancer Chemotherapy Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
7.2.2. Specialty Centers
7.2.2.1. Specialty Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Hospitals & Clinics
7.2.3.1. Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Others
7.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Cancer Chemotherapy Market By Country
8.1. North America Cancer Chemotherapy Overview
8.2. U.S.
8.2.1. U.S. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.2.2. U.S. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.3. U.S. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.2.4. U.S. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Canada
8.3.1. Canada Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
8.3.2. Canada Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.3. Canada Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
8.3.4. Canada Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. North America PEST Analysis

CHAPTER 9. Europe Cancer Chemotherapy Market By Country
9.1. Europe Cancer Chemotherapy Market Overview
9.2. U.K.
9.2.1. U.K. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.2.2. U.K. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.2.3. U.K. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.4. U.K. Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.3. Germany
9.3.1. Germany Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.3.2. Germany Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.3.3. Germany Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.4. Germany Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.4. France
9.4.1. France Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.4.2. France Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.4.3. France Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.4.4. France Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.5. Spain
9.5.1. Spain Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.5.2. Spain Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.5.3. Spain Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.5.4. Spain Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
9.6.2. Rest of Europe Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.6.3. Rest of Europe Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.6.4. Rest of Europe Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Cancer Chemotherapy Market By Country
10.1. Asia Pacific Cancer Chemotherapy Market Overview
10.2. China
10.2.1. China Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.2.2. China Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.3. China Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.2.4. China Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Japan
10.3.1. Japan Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.3.2. Japan Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.3. Japan Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.3.4. Japan Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. India
10.4.1. India Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.4.2. India Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.3. India Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.4.4. India Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.5. Australia
10.5.1. Australia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.5.2. Australia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.5.3. Australia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.5.4. Australia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.6.2. South Korea Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.6.3. South Korea Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.6.4. South Korea Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
10.7.2. Rest of Asia-Pacific Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.7.3. Rest of Asia-Pacific Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
10.7.4. Rest of Asia-Pacific Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Cancer Chemotherapy Market By Country
11.1. Latin America Cancer Chemotherapy Market Overview
11.2. Brazil
11.2.1. Brazil Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
11.2.2. Brazil Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.2.3. Brazil Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.4. Brazil Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
11.3.2. Mexico Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.3.3. Mexico Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.4. Mexico Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
11.4.2. Rest of Latin America Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.4.3. Rest of Latin America Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027

CHAPTER 12. Middle East & Africa Cancer Chemotherapy Market By Country
12.1. Middle East & Africa Cancer Chemotherapy Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
12.2.2. Saudi Arabia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.2.3. Saudi Arabia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.2.4. Saudi Arabia Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.3. UAE
12.3.1. UAE Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
12.3.2. UAE Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.3.3. UAE Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.3.4. UAE Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Indication, 2016-2027
12.4.2. Rest of Middle East & Africa Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.4.3. Rest of Middle East & Africa Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.4.4. Rest of Middle East & Africa Cancer Chemotherapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027

CHAPTER 13. Player Analysis Of Cancer Chemotherapy
13.1. Cancer Chemotherapy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Cancer Chemotherapy Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE
14.1. Bristol-Myers Squibb Company
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Bristol-Myers Squibb Company 2019 Cancer Chemotherapy Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Celgene Corporation
14.3. Eli Lilly and Company
14.4. F. Hoffmann-La Roche Ltd
14.5. GlaxoSmithKline PLC
14.6. Johnson & Johnson Indication Inc
14.7. Merck & Co. Inc.
14.8. Novartis AG
14.9. Pfizer Inc.
14.10. Sanofi S.A.
14.11. Others


Cart Summary